Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion type Assertion NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_head.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_provenance.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion evidence source_evidence_literature NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_provenance.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion SIO_000772 15590749 NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_provenance.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion wasDerivedFrom gad-20150221 NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_provenance.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion wasGeneratedBy ECO_0000203 NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_provenance.